NATIONAL CANCER CENTER HOSPITAL EAST
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
Lenvatinib and Pembrolizumab Simultaneous Combination Study
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- National Cancer Center Hospital East
- Target Recruit Count
- 29
- Registration Number
- NCT03609359
- Locations
- 🇯🇵
NationalCCHE, Kashiwa, Tokyo, Japan
© Copyright 2025. All Rights Reserved by MedPath